BEIJING and GUANGZHOU, China, March 2, 2026 /PRNewswire/ -- SALIAI ("Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd." and "Guangzhou SALIAI Biological Gene Engineering Co., Ltd.," collectively referred to as "SALIAI") is a China-based biotechnology company engaged in stem cell research and related commercial applications. The Company states that it was the first stem cell-focused company quoted on the National Equities Exchange and Quotations (NEEQ), China's New Third Board market.
SALIAI develops and commercializes cellular extract–based products and related technologies. Its activities include research and development in cell-based cosmeceuticals and investigational programs in regenerative medicine.
In February 2026, Shangpu Group, a China-based research and advisory firm, issued SALIAI a "Global Pioneer in Patented Cellular Essence" market position statement following what it described as a global market study. According to Shangpu Group, the designation reflects its assessment of SALIAI's technological position within a defined market segment and does not constitute a regulatory classification, certification, or government endorsement.
SALIAI holds High-Tech Enterprise status in China and has been designated as a National Enterprise Technology Center in stem cell. It has also received national intellectual property recognition. Founded in 2009 and headquartered at Guangzhou International Bio Island, the company conducts cellular research and develops related commercial applications. Its operations include laboratory research, process development, and manufacturing of patented cellular extracts.
The Company reports holding more than 300 authorized patents, including five recipients of the National Patent Excellence Award. Its patent portfolio includes technologies related to umbilical cord–derived extracts and exosome-associated processes, with certain patents granted in both China and the United States. The Company participates in more than 30 research projects at the national, provincial, and municipal levels.
SALIAI has been engaged in stem cell research for approximately 16 years. Led by Founder Dr. Chen Haijia, the Company maintains a scientific and technical team focused on cellular research and related applications. Academician Su Guohui serves as Chief Scientist. The Company operates research facilities, including government-designated Academician Workstations, and maintains a GMP-compliant manufacturing facility with ISO and CNAS certifications.
Its proprietary freeze-drying process, conducted at minus 40 degrees Celsius, is designed to preserve cellular material under controlled conditions. In combination with nano-scale delivery systems, the technology is intended to support formulation stability and topical delivery in cosmetic applications.
Commercial products include SYDRAW Intelligent Polypeptide Lyophilized Powder and Bio Island Anti-Wrinkle and Firming Essence Set, which are marketed within China's cosmetics sector. The products have undergone third-party testing and have received the designation "Guangdong Premium Cosmetics," a provincial quality recognition.
SALIAI focuses on science-based product development in skincare and cellular technologies. The Company participated in the development of three national association standards related to cellular extracts, contributing to technical guidelines within its industry.
The Company also serves in leadership roles within industry associations and has organized the International Stem Cell and Precision Medicine Industrialization Conference annually for the past ten years.
Through research collaborations with medical institutions—including studies related to stem cell approaches for knee osteoarthritis—the Company conducts clinical research programs at various stages of development.
The Company also supports corporate social responsibility initiatives, including funding the construction of Hope Primary Schools in China and establishing science and technology innovation funds. Its corporate mission is: "Science and love will guard life."
SALIAI intends to continue investing in research and development related to its patented cellular technologies. The Company is conducting clinical research programs involving stem cell–based therapeutic candidates, including investigational approaches related to knee osteoarthritis, subject to applicable regulatory and clinical trial requirements.
The Company is implementing digital systems to support manufacturing oversight, quality management, and operational processes as it expands internationally.
SALIAI is establishing a Stem Cell Innovation Association in the Guangdong-Hong Kong-Macao Greater Bay Area to support research translation and commercial collaboration across cosmeceuticals and regenerative medicine.
The Company aims to expand the international application of its cellular research and product development capabilities. Its corporate vision is: "Make health and beauty within reach."
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Shangpu Group Issues Market Position Statement Recognizing SALIAI's Patented Cellular Essence Global Pioneer
BARCELONA, Spain, March 2, 2026 /PRNewswire/ -- vivo today offered a first look at its upcoming top-tier imaging flagship, the X300 Ultra, at MWC Barcelona 2026, showcasing its design alongside the industry-leading 400mm Equivalent vivo ZEISS Telephoto Extender Gen 2 Ultra[1], which serves as a key component of its professional photography kit. For the first time, vivo confirmed plans to launch this most advanced X-series model in global markets later this year, further strengthening its influence in both the professional imaging sector and the premium smartphone market.
Making its global debut as the industry's only 400mm telephoto extender, the vivo ZEISS Telephoto Extender Gen2 Ultra, showcased on-site, pushes the boundaries of mobile imaging with pro-grade optical performance. As mobile imaging shifts toward pro-grade expression, a superior telephoto extender is now defined not just by its reach, but by systemic breakthroughs across magnification, optical performance, stabilization, and structural design. To this end, the X300 Ultra features the industry-leading 400mm-equivalent telephoto extender, achieving an excellent balance between powerful zoom capabilities and its body structure. Co-engineered with ZEISS, the lens is designed to meet APO imaging standards and supports a full 200MP optical output, delivering pristine image quality even at a 1600mm digital crop. Furthermore, with cutting-edge gimbal-grade OIS and motion-tracking focus technology, it delivers an exceptionally stable and precise telephoto experience. This flagship solution drives powerful momentum for professional creators, setting a new bar for ultra-long-range snapshots and mobile telephoto video.
Following the Telephoto Extender, vivo has introduced a pro-grade Camera Cage designed to elevate the video shooting capabilities of X300 Ultra. The expandable cage features an array of cold shoe mounts and quick-release ports for seamless accessory integration, paired with a dual-hand grip to ensure outstanding stability during demanding handheld shoots. To provide precise creative control, the cage further incorporates dedicated physical buttons for tactile shutter and zoom adjustment, while an integrated, multi-level cooling fan maintains peak performance during high-intensity recording. In addition, the External Lens Expansion Frame offers full compatibility with the X300 Ultra Telephoto Extender, rounding out a comprehensive toolkit for professionals.
X300 Ultra builds on vivo's long-standing investment in imaging technologies, spanning optics engineering, computational photography, and system-level optimization. Previous Ultra models have gained broad recognition for their advances in mobile photography and videography, establishing vivo's reputation in high-end mobile imaging. The decision to introduce X300 Ultra to international markets signals vivo's more proactive and confident approach to expanding its presence in the global premium smartphone segment, while reinforcing its vision of bringing its most advanced imaging capabilities to a broader audience worldwide.
Led by the X300 Ultra, vivo's showcase at MWC 2026 underscores its steadfast commitment to pioneering imaging innovation and delivering premium products to a global audience. Looking ahead, vivo will continue to uphold its user-oriented philosophy, deepening its expertise in core areas such as professional-grade imaging and exquisite design to propel the industry toward a new frontier.
(END)
About vivo
vivo is a technology company that creates great products based on a design-driven value, with smart devices and intelligent services as its core. The company aims to build a bridge between humans and the digital world. Through unique creativity, vivo provides users with an increasingly convenient mobile and digital life. Following the company's core values, which include Benfen*, user-orientation, design-driven value, continuous learning and team spirit, vivo has implemented a sustainable development strategy with the vision of developing into a healthier, more sustainable world-class corporation.
While bringing together and developing the best local talents to deliver excellence, vivo is supported by a network of R&D centers in Shenzhen, Dongguan, Nanjing, Beijing, Hangzhou, Shanghai, Xi'an and more cities, focusing on the development of state-of-the-art consumer technologies, including 5G, artificial intelligence, industrial design, imaging system and other up-and-coming technologies. vivo has also set up an intelligent manufacturing network (including those authorized by vivo), with an annual production capacity of nearly 200 million smartphones. As of now, vivo has branched out its sales network across more than 60 countries and regions, and is loved by more than 500 million users worldwide.
*"Benfen" is a term describing the attitude on doing the right things and doing things right – which is the ideal description of vivo's mission to create value for society.
Stay informed of latest vivo news at https://www.vivo.com/en/about-vivo/news
| [1] "400 mm Equivalent vivo ZEISS Telephoto Extender Gen 2 Ultra" refers to using the X300 Ultra together with the "vivo ZEISS Telephoto Extender Gen 2 Ultra" and enabling the "Telephoto Extender" switch in the Camera app, which allows the device to achieve a 400 mm equivalent optical focal length. |
[1] "400 mm Equivalent vivo ZEISS Telephoto Extender Gen 2 Ultra" refers to using the X300 Ultra together with the "vivo ZEISS Telephoto Extender Gen 2 Ultra" and enabling the "Telephoto Extender" switch in the Camera app, which allows the device to achieve a 400 mm equivalent optical focal length.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
vivo Unveils Flagship X300 Ultra at MWC 2026: Showcasing Pioneering 400mm Equivalent vivo ZEISS Telephoto Extender Gen 2 Ultra and Announcing Global Availability
vivo Unveils Flagship X300 Ultra at MWC 2026: Showcasing Pioneering 400mm Equivalent vivo ZEISS Telephoto Extender Gen 2 Ultra and Announcing Global Availability
